1. OC-16 Apixaban as treatment for cancer-associated venous thrombosis: the CAP study. Issue 200 (April 2021) Authors: Hannevik, T.L.; Brekke, J.; Enden, T.; Frøen, H.; Garresori, H.; Ghanima, W.; Jacobsen, E.M.; Paulsen, P.Q.; Porojnicu, A.C.; Ree, A.H.; Sandset, P.M.; Torfoss, D.; Velle, E.O.; Wik, H.S.; Dahm, A.E.A. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Issue 163 (March 2018) Authors: Utne, K.K.; Dahm, A.; Wik, H.S.; Jelsness-Jørgensen, L.P.; Sandset, P.M.; Ghanima, W. Journal: Thrombosis research Issue: Issue 163(2018) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗